Ross Langley

810 total citations
31 papers, 443 citations indexed

About

Ross Langley is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Ecology. According to data from OpenAlex, Ross Langley has authored 31 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Ecology. Recurrent topics in Ross Langley's work include Bacteriophages and microbial interactions (6 papers), Obstructive Sleep Apnea Research (5 papers) and Antimicrobial Peptides and Activities (4 papers). Ross Langley is often cited by papers focused on Bacteriophages and microbial interactions (6 papers), Obstructive Sleep Apnea Research (5 papers) and Antimicrobial Peptides and Activities (4 papers). Ross Langley collaborates with scholars based in United Kingdom, United States and Canada. Ross Langley's co-authors include John R. W. Govan, Perdita E. Barran, Dominic J. Campopiano, Julia R. Dorin, David J. Clarke, Alison Maxwell, Nick C. Polfer, Steve Cunningham, Peter Vandamme and D. Kenna and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Ross Langley

27 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross Langley United Kingdom	13	123	112	78	66	53	31	443
Sunhwa Lee South Korea	17	105 0.9×	68 0.6×	61 0.8×	7 0.1×	24 0.5×	46	700
Thushara Galbadage United States	10	73 0.6×	25 0.2×	39 0.5×	7 0.1×	25 0.5×	19	443
Jacob S. Stevens United States	15	176 1.4×	16 0.1×	47 0.6×	26 0.4×	143 2.7×	34	959
David J. Roach United States	15	182 1.5×	21 0.2×	246 3.2×	98 1.5×	41 0.8×	34	922
William H. Halliwell United States	10	155 1.3×	16 0.1×	50 0.6×	18 0.3×	12 0.2×	14	574
Qi Guo China	13	208 1.7×	18 0.2×	66 0.8×	7 0.1×	22 0.4×	49	646
Katherine Sebastian United States	12	97 0.8×	9 0.1×	18 0.2×	57 0.9×	8 0.2×	37	618
Magdalena Orczyk‐Pawiłowicz Poland	15	265 2.2×	14 0.1×	129 1.7×	16 0.2×	7 0.1×	45	874
K. Katz United States	6	140 1.1×	65 0.6×	20 0.3×	10 0.2×	10 0.2×	8	468
Diane E. Renaud United States	15	210 1.7×	35 0.3×	35 0.4×	5 0.1×	9 0.2×	18	763

Countries citing papers authored by Ross Langley

Since Specialization

Citations

This map shows the geographic impact of Ross Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Langley more than expected).

Fields of papers citing papers by Ross Langley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Langley. The network helps show where Ross Langley may publish in the future.

Co-authorship network of co-authors of Ross Langley

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Langley. A scholar is included among the top collaborators of Ross Langley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Langley. Ross Langley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Langley, Ross, et al.. (2025). E‐Cigarette Education and Training in Medical Schools: A National Survey. Pediatric Pulmonology. 60(5). e71125–e71125.

Selby, Anna, Matthew Davies, Catherine M. Hill, et al.. (2024). Role of overnight oximetry in assessing the severity of obstructive sleep apnoea in typically developing children: a multicentre study. Archives of Disease in Childhood. 109(4). 308–313. 2 indexed citations

Mazurka, Raegan, Lucy Chen, Ross Langley, et al.. (2024). Preferences for virtual versus in-person mental and physical healthcare in Canada: a descriptive study from a cohort of youth and their parents enriched for severe mental illness. BMJ Paediatrics Open. 8(1). e002197–e002197. 2 indexed citations

Davies, P. S. W., et al.. (2024). Paediatric sleep diagnostics in the 21st century: the era of “sleep-omics”?. European Respiratory Review. 33(172). 240041–240041. 1 indexed citations

Jones, Joshua D., Helen J. Stacey, John W. Kennedy, et al.. (2024). How to: assess patient suitability for unlicensed phage therapy in the United Kingdom. Clinical Microbiology and Infection. 31(1). 57–61.

Beres, Stephen B., Randall J. Olsen, S. Wesley Long, et al.. (2024). Increase in invasive Streptococcus pyogenes M1 infections with close evolutionary genetic relationship, Iceland and Scotland, 2022 to 2023. Eurosurveillance. 29(13). 14 indexed citations

Evans, Hazel, Neil Gibson, Joanna Bennett, et al.. (2023). British Thoracic Society guideline for diagnosing and monitoring paediatric sleep-disordered breathing. Thorax. 78(Suppl 2). s1–s27. 18 indexed citations

Evans, Hazel, Neil Gibson, Joanna Bennett, et al.. (2023). British Thoracic Society Guideline for diagnosing and monitoring paediatric sleep-disordered breathing. Thorax. 78(10). 1043–1054. 16 indexed citations

Jones, Joshua D., et al.. (2023). Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom. Antibiotics. 12(3). 502–502. 5 indexed citations

10.

Stacey, Helen J., et al.. (2023). Phage therapy: Awareness and demand among clinicians in the United Kingdom. PLoS ONE. 18(11). e0294190–e0294190. 4 indexed citations

11.

Langley, Ross, et al.. (2023). Manifestation of depression in speech overlaps with characteristics used to represent and recognize speaker identity. Scientific Reports. 13(1). 11155–11155. 12 indexed citations

12.

Langley, Ross, et al.. (2022). Toxic and addictive effects of nicotine on children and adolescents: are we sleepwalking into a public health disaster?. Archives of Disease in Childhood. 108(9). 691–692. 3 indexed citations

13.

Jones, Joshua D., et al.. (2022). The potential of bacteriophage therapy in the treatment of paediatric respiratory infections. Paediatric Respiratory Reviews. 44. 70–77. 7 indexed citations

14.

Williams, Thomas, Clare MacRae, Olivia Swann, et al.. (2021). Indirect effects of the COVID-19 pandemic on paediatric healthcare use and severe disease: a retrospective national cohort study. Archives of Disease in Childhood. 106(9). 911–917. 63 indexed citations

15.

Thomas, Matthew F., et al.. (2021). Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study. Archives of Disease in Childhood. 107(5). 479–485. 7 indexed citations

16.

Langley, Ross, Laura Hill, Elizabeth A. Hill, & Don S. Urquhart. (2017). The curious incident of groaning in the night-time. Breathe. 13(2). 123–126. 3 indexed citations

17.

Langley, Ross & Steve Cunningham. (2017). How Should Oxygen Supplementation Be Guided by Pulse Oximetry in Children: Do We Know the Level?. Frontiers in Pediatrics. 4. 138–138. 16 indexed citations

18.

Campopiano, Dominic J., David J. Clarke, Nick C. Polfer, et al.. (2004). Structure-Activity Relationships in Defensin Dimers. Journal of Biological Chemistry. 279(47). 48671–48679. 80 indexed citations

19.

Kenna, D., Victoria A. Barcus, Ross Langley, Peter Vandamme, & John R. W. Govan. (2003). Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in theBurkholderia cepaciacomplex. FEMS Immunology & Medical Microbiology. 35(2). 87–92. 16 indexed citations

20.

Meyer, Ralph M., M Gyger, Ross Langley, Bernard Lespérance, & Stephen Caplan. (1998). A Phase I Trial of Standard and Cyclophosphamide Dose-Escalated CHOP with Granulocyte Colony Stimulating Factor in Elderly Patients with Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 30(5-6). 591–600. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact